make minor chang forecast ebitda increas target price
due mark market multipl due
increas mid-term growth assumpt retain
outperform rate symris back integr raw materi
menthol/pinova believ compani use win market
share competitor struggl sourc ingredi share gain
assist plant ramp sustain high-
singl doubl digit top-line growth margin upsid mid-term
market share gain symris report organ growth
doubl peer givaudan sensient symris
organ growth averag peer industri
consolid led acceler growth premium diana
revenu synergi led ytd symris organ grow busi
competit believ current out-performance led
symris superior vertic integr raw materi creat abil
serv custom competit struggl suppli issu eg
basf citral/aroma china vanilla onion compani continu prove
custom new project ramp start
capit share gain
invest set acceler growth group
forecast volum growth led share gain acceler
led ramp major invest project cosmet food
menthol estim cumul growth contribut six signific
growth project invest ramp support
mid-high singl digit organ growth mid-term peer wider
valuat tp averag peer multipl dcf
key risk acceler raw materi price increas
valuat metric
price month
price rel chart measur perform
deutsch bors dax close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
symris global provid fragranc flavor activ
ingredi aroma chemic well sensori nutrit
solut perfum cosmet pharmaceut food beverag
pet food babi food industri
price aug rate outperform target price analyst mathew hampshire-waugh
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
high singl digit growth ebitda multipl compar
base case scenario mid-high singl digit organ growth
ebitda margin ebitda multipl
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
digit growth ebitda multipl compar base
case scenario mid-high singl digit organ growth
ebitda margin ebitda multipl
price rel chart measur perform deutsch
bors dax close
spot exchang rate
decreas forecast ebitda key chang follow
scent increas fy organ growth follow
strong perform assum organ growth support market
share gain driven suppli chain issu competit stem basf
citral outag shutdown china/india maintain margin
follow margin
flavour nutrit reduc fy ebitda due margin
reduct forecast ebitda margin
function normal margin profit improv probi toward
cobel margin improv continu assum pressur
raw materi price off-set
forecast organ ebitda growth driven organ revenu
growth non-organ item follow
cobel acquisit assum addit month cobel
improv margin
probi warn probi custom destock neg impact symris ebitda
yoy howev revers fy run weaker
compar probi sale profit improv back toward
ebitda
fx headwind primarili weaker usd
new invest includ contribut pet food franc flavour
usa cosmet usa plu diana food usa equat
renessenz/pinova synergi synergi
basf citral impact assum adjust margin impact
due raw materi price increas link basf citral outag
sale pinova industri
nutraceutix probi acquisit
new invest
basf citral impact
symris trade premium peer consensu month forward
ev/ebitda premium year averag trade premium
month forward price-to-earnings basi symris current trade premium peer
premium year histor averag premium
euro stoxx rel
figur symris pe rel peer
figur symris ev/ebitda rel peer
compani mention price
